Kowa Company, Ltd. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Kowa Company, Ltd. - Product Pipeline Review - 2016

Kowa Company, Ltd. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Kowa Company, Ltd. - Product Pipeline Review - 2016
Published Aug 17, 2016
53 pages — Published Aug 17, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Kowa Company, Ltd. - Product Pipeline Review - 2016, provides an overview of the Kowa Company, Ltd.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Kowa Company, Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Kowa Company, Ltd.
- The report provides overview of Kowa Company, Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Kowa Company, Ltd.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Kowa Company, Ltd.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Kowa Company, Ltd.s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Kowa Company, Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Kowa Company, Ltd.s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08120CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Kowa Company, Ltd. Snapshot61
  Kowa Company, Ltd. Overview61
  Key Information61
  Key Facts61
Kowa Company, Ltd. Research and Development Overview73
  Key Therapeutic Areas73
Kowa Company, Ltd. Pipeline Review104
  Pipeline Products by Stage of Development101
  Pipeline Products Monotherapy111
  Pipeline Products Partnered Products121
    Partnered Products/Combination Treatment Modalities131
Kowa Company, Ltd. Pipeline Products Glance147
  Kowa Company, Ltd. Late Stage Pipeline Products141
    Pre-Registration Products/Combination Treatment Modalities141
    Phase III Products/Combination Treatment Modalities151
  Kowa Company, Ltd. Clinical Stage Pipeline Products161
    Phase II Products/Combination Treatment Modalities161
    Phase I Products/Combination Treatment Modalities171
  Kowa Company, Ltd. Early Stage Pipeline Products181
    Preclinical Products/Combination Treatment Modalities181
    Discovery Products/Combination Treatment Modalities191
  Kowa Company, Ltd. - Unknown Stage Pipeline Products201
    Unknown Products/Combination Treatment Modalities201
Kowa Company, Ltd. Drug Profiles2117
  pemafibrate211
    Product Description211
    Mechanism of Action211
    R&D Progress213
  anagliptin241
    Product Description241
    Mechanism of Action241
    R&D Progress242
  peretinoin261
    Product Description261
    Mechanism of Action261
    R&D Progress262
  K-134281
    Product Description281
    Mechanism of Action281
    R&D Progress281
  ripasudil291
    Product Description291
    Mechanism of Action291
    R&D Progress292
  epirubicin hydrochloride311
    Product Description311
    Mechanism of Action311
    R&D Progress311
  K-312321
    Product Description321
    Mechanism of Action321
    R&D Progress321
  pitavastatin NP331
    Product Description331
    Mechanism of Action331
    R&D Progress331
  Small Molecule to Agonize LXRB for Atherosclerosis341
    Product Description341
    Mechanism of Action341
    R&D Progress341
  Small Molecule to Inhibit Acyl-Coenzyme A for Undisclosed Indication351
    Product Description351
    Mechanism of Action351
    R&D Progress351
  Small Molecule for Oncology361
    Product Description361
    Mechanism of Action361
    R&D Progress361
  K-163SZ371
    Product Description371
    Mechanism of Action371
    R&D Progress371
Kowa Company, Ltd. Pipeline Analysis386
  Kowa Company, Ltd. Pipeline Products by Target382
  Kowa Company, Ltd. Pipeline Products by Route of Administration401
  Kowa Company, Ltd. Pipeline Products by Molecule Type411
  Kowa Company, Ltd. Pipeline Products by Mechanism of Action422
Kowa Company, Ltd. Recent Pipeline Updates443
Kowa Company, Ltd. Dormant Projects471
Kowa Company, Ltd. - Discontinued Pipeline Products481
  Discontinued Pipeline Product Profiles481
    pitavastatin CR481
Kowa Company, Ltd. Locations And Subsidiaries493
  Head Office491
  Other Locations &Subsidiaries493
Appendix522
  Methodology521
  Coverage521
  Secondary Research521
  Primary Research521
  Expert Panel Validation521
  Contact Us521
  Disclaimer531

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Kowa Company, Ltd. - Product Pipeline Review - 2016" Aug 17, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Kowa-Company-Ltd-Product-Pipeline-Review-2016-2088-16406>
  
APA:
Global Markets Direct - Market Research. (2016). Kowa Company, Ltd. - Product Pipeline Review - 2016 Aug 17, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Kowa-Company-Ltd-Product-Pipeline-Review-2016-2088-16406>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.